Anika Therapeutics Inc. · Transaction Mar 2, 2020 · Filed Mar 5, 2021 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · ANIK
-1.05% · -$0.2200 · Vol 118.5K
Market closed · last close 4:00 PM ET · price as of 16:15:21 ET
Anika Therapeutics Inc
Biotechnology
$20.81
Follow $ANIK
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ANIK by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredFri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET · ANIK
MethodologyANIK
Anika Therapeutics Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
72/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is ANIK moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Anika Therapeutics Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
1993
Employees
235
Country
US
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$21.03
Day high
$21.05
Day low
$20.55
Previous close
$21.03
52W high
$22.03
-5.54% from high
52W low
$9.00
91% of range
Market cap
$278.5M
EPS
$-0.5400
Beta
0.32
Shares out
13.4M
Volume
118.5K
1.13× rel vol
Avg volume
104.9K
VWAP
$20.80
Price history computed in-house
1W
-0.24%
1M
-4.45%
3M
+46.55%
1Y
+133.82%
YTD
+116.55%
SMA 50 $19.36 · above
SMA 200 $14.45 · above
52W position 91%
ANIK overview
Related filings and maps
Public disclosures
Congress activity in ANIK
Official filing ↗
ANIK · Transaction Mar 2, 2020 · Filed Mar 5, 2021 · $1,001 to $15,000
ANIK · Transaction Feb 28, 2020 · Filed Aug 26, 2021 · $1,001 to $15,000
ANIK · Transaction Feb 27, 2020 · Filed Aug 26, 2021 · $1,001 to $15,000
Tom MalinowskiSell
ANIK · Transaction Jan 28, 2020 · Filed Aug 26, 2021 · $1,001 to $15,000
Federal contracts
ANIK contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ANIK in this window.
Lobbying spend
ANIK lobbying filings, year to date.
Registered lobbying filings matched to Anika Therapeutics Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ANIK in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for ANIK.
Options
Sovereign unlock shows live options positioning for ANIK.